DoseCraft
VapeHeatLab
NAB - TEST - Khalifa Kush
About
NAB - TEST - Khalifa Kush is a hybrid cannabis strain. Lab samples test between 19.3% and 26.1% THC, with caryophyllene (1.10%) as the dominant terpene.
Why does NAB - TEST - Khalifa Kush feel pain-relieving?
NAB - TEST - Khalifa Kush's pain-relieving effects are linked to its dominant caryophyllene (1.10%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by humulene (0.53%), associated with appetite suppression and anti-inflammatory effects.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 19.3–26.1%
- CBD
- 0.1%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout NAB - TEST - Khalifa Kush
- NAB - TEST - Khalifa Kush is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- NAB - TEST - Khalifa Kush typically tests at 19.3% to 26.1% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
- The dominant terpenes in NAB - TEST - Khalifa Kush are Caryophyllene, Humulene, Limonene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.